Technical Analysis for AXSM - Axsome Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 200 DMA | Bearish | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Slingshot Bearish | Bearish Swing Setup | -3.97% | |
Crossed Above 200 DMA | Bullish | -3.97% | |
Pocket Pivot | Bullish Swing Setup | -3.97% | |
Multiple of Ten Bullish | Other | -3.97% | |
Wide Bands | Range Expansion | -3.97% | |
Oversold Stochastic | Weakness | -3.97% | |
Doji - Bullish? | Reversal | 4.01% | |
Multiple of Ten Bearish | Other | 4.01% |
Alert | Time |
---|---|
10 DMA Support | about 17 hours ago |
60 Minute Opening Range Breakdown | about 20 hours ago |
Down 3% | about 23 hours ago |
Rose Above Previous Day's High | about 23 hours ago |
Fell Below 200 DMA | about 23 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/20/2024
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of pain and other central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of pain in patients with complex regional pain syndrome; and AXS-05 for the treatment of agitation in patients with Alzheimer's disease and treatment resistant depression. The company is also developing AXS-02 for the treatment of knee osteoarthritis and chronic low back pain, as well as a preclinical development program AXS-06 for the treatment of chronic pain disorders. Axsome Therapeutics, Inc. was founded in 2012 and is based in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pain Organ Systems Clinical Development Alzheimer's Disease Chronic Pain Pain Management Central Nervous System Disorders Nervous System Disorders Depression Knee Osteoarthritis Chronic Condition Antidepressants Treatment Of Chronic Pain Back Pain Treatment Resistant Depression
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pain Organ Systems Clinical Development Alzheimer's Disease Chronic Pain Pain Management Central Nervous System Disorders Nervous System Disorders Depression Knee Osteoarthritis Chronic Condition Antidepressants Treatment Of Chronic Pain Back Pain Treatment Resistant Depression
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 98.4 |
52 Week Low | 55.0276 |
Average Volume | 760,661 |
200-Day Moving Average | 75.37 |
50-Day Moving Average | 85.09 |
20-Day Moving Average | 76.83 |
10-Day Moving Average | 72.28 |
Average True Range | 3.68 |
RSI (14) | 39.76 |
ADX | 30.25 |
+DI | 20.76 |
-DI | 26.12 |
Chandelier Exit (Long, 3 ATRs) | 84.21 |
Chandelier Exit (Short, 3 ATRs) | 79.63 |
Upper Bollinger Bands | 86.82 |
Lower Bollinger Band | 66.85 |
Percent B (%b) | 0.29 |
BandWidth | 26.00 |
MACD Line | -4.12 |
MACD Signal Line | -3.83 |
MACD Histogram | -0.2973 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 77.93 | ||||
Resistance 3 (R3) | 78.41 | 77.11 | 77.03 | ||
Resistance 2 (R2) | 77.11 | 75.74 | 76.86 | 76.73 | |
Resistance 1 (R1) | 74.82 | 74.89 | 74.17 | 74.34 | 76.43 |
Pivot Point | 73.52 | 73.52 | 73.19 | 73.27 | 73.52 |
Support 1 (S1) | 71.23 | 72.15 | 70.58 | 70.75 | 68.65 |
Support 2 (S2) | 69.93 | 71.30 | 69.68 | 68.35 | |
Support 3 (S3) | 67.64 | 69.93 | 68.05 | ||
Support 4 (S4) | 67.16 |